Glomerulonephritis, IGA: all 263 studies
Page 2 of 3. Open to participants first (102), then studies with results posted, then the rest; newest registration first within each.
- IgA Nephropathy Biomarkers Evaluation Study (INTEREST)RecruitingNCT02954419
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)RecruitingNCT01802034
- A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgANCompletedNCT05856760Phase 2Results posted
- Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyCompletedNCT05834738Phase 2Results posted
- Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)TerminatedNCT05162066Phase 2Results posted
- Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)TerminatedNCT05097989Phase 2Results posted
- Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA NephropathyCompletedNCT05065970Phase 2Results posted
- Atacicept in Subjects With IgA NephropathyActive, not recruitingNCT04716231Phase 3Results posted
- Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)TerminatedNCT04564339Phase 2Results posted
- Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)CompletedNCT04541043Phase 3Results posted
- Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2Results posted
- Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA NephropathyTerminatedNCT04042623Phase 2Results posted
- A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)TerminatedNCT03841448Phase 2Results posted
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyCompletedNCT03762850Phase 3Results posted
- First in Human Study to Assess Safety of VIS649 in Healthy SubjectsCompletedNCT03719443Phase 1Results posted
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) NephropathyCompletedNCT03643965Phase 3Results posted
- Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) NephropathyTerminatedNCT03608033Phase 3Results posted
- Phase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesCompletedNCT03453619Phase 2Results posted
- Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by InflammationCompletedNCT03373461Phase 2Results posted
- A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIXCompletedNCT03366337Phase 2Results posted
- Efficacy and Safety of Atacicept in IgA NephropathyTerminatedNCT02808429Phase 2Results posted
- Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721TerminatedNCT02682407Phase 2Results posted
- Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS BlockadeCompletedNCT02384317Phase 2Results posted
- Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionCompletedNCT02282930Phase 3Results posted
- Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) NephropathyCompletedNCT02112838Phase 2Results posted
- Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney DiseaseTerminatedNCT01129557Phase 4Results posted
- Pilot Study of Velcade® in IgA NephropathyCompletedNCT01103778Phase 4Results posted
- A Controlled Study of Uric Acid on the Progression of IgA NephropathyCompletedNCT00793585Not applicableResults posted
- Rituximab in Progressive Immunoglobulin A (IgA) NephropathyCompletedNCT00498368Phase 4Results posted
- Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.CompletedNCT00446459Phase 2Results posted
- Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal TransplantCompletedNCT00446251Phase 2Results posted
- Mycophenolate Mofetil (MMF) in Patients With IgA NephropathyTerminatedNCT00318474Phase 3Results posted
- Model Development and Application Based on Renal Pathology ImagesActive, not recruitingNCT07816874
- A Study of Treatment Patterns and Real-World Outcomes in IgA Nephropathy Patients in the United StatesCompletedNCT07757048
- Serum and Urinary sCD163 in IgA NephropathyCompletedNCT07754019
- A Phase IIa Study in Primary IgA Nephropathy PatientsCompletedNCT07634744Phase 2
- Exploring the Brain - Gut Microbiota - Kidney Interactive Damage Mechanisms Underlying Cognitive Decline in Patients With IgA Nephropathy Using Ultra-high Field Magnetic Resonance ImagingCompletedNCT07617402
- Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS DataCompletedNCT07607002
- A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal ImpairmentActive, not recruitingNCT07445906Phase 1
- A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA NephropathyActive, not recruitingNCT07305974Phase 2
- To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA NephropathyActive, not recruitingNCT07098897Phase 3
- A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy SubjectsCompletedNCT07035665Phase 1
- Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy PatientsWithdrawnNCT07022574Not applicable
- Monthly Dosing of Atacicept in IgANActive, not recruitingNCT07020923Phase 2
- An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA NephropathyWithdrawnNCT06926985Early Phase 1
- Relative Bioavailability Study of HR19042 in Healthy SubjectsCompletedNCT06922305Phase 1
- A Study of SGB-9768 in Patients With Complement-mediated Kidney DiseasesActive, not recruitingNCT06786338Phase 2
- A Study of Probiotics in IgA NephropathyCompletedNCT06767592Not applicable
- Phase 2b Open-Label Repeat Kidney Biopsy StudyActive, not recruitingNCT06740526Phase 2
- Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA NephropathyActive, not recruitingNCT06712407Phase 4
- Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANCompletedNCT06670352Phase 2
- Replication of the NefIgArd Trial of TRF-budesonide in Primary IgANCompletedNCT06589752
- Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)Active, not recruitingNCT06564142Phase 3
- Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA NephropathyCompletedNCT06460987
- Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Active, not recruitingNCT06291376Phase 3
- Study of ARO-CFB in Adult Healthy VolunteersCompletedNCT06209177Phase 1
- A Trial of HRS-5965 Tablets in Primary IgA NephropathyCompletedNCT06137768Phase 2
- A Study of Zigakibart in Adults With IgA NephropathyActive, not recruitingNCT05852938Phase 3
- Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA NephropathyTerminatedNCT05847920Phase 2
- A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA NephropathyStatus unknownNCT05824390Phase 4
- A Study of Telitacicept for IgA Nephropathy (TELIGAN)Active, not recruitingNCT05799287Phase 3
- A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionActive, not recruitingNCT05797610Phase 3
- Application of Hyperspectral Imaging in the Diagnosis of Glomerular DiseasesStatus unknownNCT05797051
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
- A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney DiseaseActive, not recruitingNCT05687890Phase 2
- Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301CompletedNCT05534919Phase 3
- TESTING -ON Post-Trial ObservatioNal Cohort StudyCompletedNCT05434325
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy SubjectCompletedNCT05398510Phase 1
- Bortezomib for Treating Glomerular DiseasesStatus unknownNCT05383547Not applicable
- Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)Active, not recruitingNCT05248646Phase 3
- Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)CompletedNCT05200871
- A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA NephropathyCompletedNCT05182775Not applicable
- The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.Status unknownNCT05132621
- Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)TerminatedNCT05125068Phase 2
- Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal DiseaseCompletedNCT05083364Phase 1/2
- A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.CompletedNCT05016323Phase 2
- A Study of Telitacicept for Injection (RC18) in Subjects With IgA NephropathyTerminatedNCT04905212Phase 2
- A Trial of HR19042 Capsule in Healthy Chinese SubjectsCompletedNCT04887532Phase 1
- Steroids Therapy in IgA Nephropathy With CrescentsStatus unknownNCT04833374Phase 3
- SodiUm Restriction by Behavioral InterventionStatus unknownNCT04805047Not applicable
- Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney DiseasesCompletedNCT04689074
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsCompletedNCT04578834Phase 3
- Atrasentan in Patients With Proteinuric Glomerular DiseasesActive, not recruitingNCT04573920Phase 2
- Atrasentan in Patients With IgA NephropathyActive, not recruitingNCT04573478Phase 3
- Rituximab and RASi in Patients with IgANCompletedNCT04525729Phase 4
- The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA NephropathyStatus unknownNCT04438603
- Global Kidney Patient Trials NetworkCompletedNCT04389827
- The Clinical Trial of ADR-001 for IgA NephropathyCompletedNCT04342325Phase 1
- A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) NephropathyCompletedNCT04291781Phase 2
- Study of the IgA Repertoire During IgA Deposition Nephropathy.CompletedNCT04092491
- Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal InsufficiencyStatus unknownNCT04020328Phase 4
- A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA NephropathyCompletedNCT04014335Phase 2
- Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)CompletedNCT03945318Phase 1/2
- Fecal Microbiota Transplantation for Refractory IgA NephropathyStatus unknownNCT03633864Phase 2
- Longterm Renal Oucomes of STOP-IgAN Trial ParticipantsCompletedNCT03488368
- Effect of Immunosuppression in IgA NephropathyStatus unknownNCT03468972Phase 4
- Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRDActive, not recruitingNCT03418779Phase 2/3
- Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA NephropathyStatus unknownNCT03218852Phase 4
- Treatment of IgA Nephropathy According to Renal LesionsCompletedNCT03188887Phase 3
- Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA NephropathyStatus unknownNCT02981212Phase 4